Angiogenesis in gliomas: imaging and experimental therapeutics. - Wikidata - awgldk - TriplyDB

Angiogenesis in gliomas: imaging and experimental therapeutics.

Angiogenesis in gliomas: imaging and experimental therapeutics.

http://www.wikidata.org/entity/Q31028310

about

Glioblastoma, hypoxia and autophagy: a survival-prone 'ménage-à-trois'Galectins and gliomas.Assessment of multiparametric MRI in a human glioma model to monitor cytotoxic and anti-angiogenic drug effects Quantification of tumor vessels in glioblastoma patients using time-of-flight angiography at 7 Tesla: a feasibility study EGFR gene overexpression retained in an invasive xenograft model by solid orthotopic transplantation of human glioblastoma multiforme into nude mice.Angiogenesis-independent tumor growth mediated by stem-like cancer cells.HIV protease inhibitors decrease VEGF/HIF-1alpha expression and angiogenesis in glioblastoma cells Simultaneous targeting of two ligand-binding sites on VEGFR2 using biparatopic Affibody molecules results in dramatically improved affinity.Calpain 2 is required for the invasion of glioblastoma cells in the zebrafish brain microenvironment.OKN-007 decreases VEGFR-2 levels in a preclinical GL261 mouse glioma model.Characterization of tumor angiogenesis in rat brain using iron-based vessel size index MRI in combination with gadolinium-based dynamic contrast-enhanced MRI Immune phenotypes predict survival in patients with glioblastoma multiforme.Molecular diagnostics as a tool to personalize treatment in adult glioma patients.Antiangiogenic effects of noscapine enhance radioresponse for GL261 tumors.Inhibition of angiogenesis and invasion in malignant gliomas.Angiogenesis as a therapeutic target in malignant gliomas.Antiangiogenic strategies for treatment of malignant gliomas.Tumor antigen precursor protein profiles of adult and pediatric brain tumors identify potential targets for immunotherapy Antiangiogenic therapy and mechanisms of tumor resistance in malignant glioma.Characterization of a human tumorsphere glioma orthotopic model using magnetic resonance imaging.Measurable Supratentorial White Matter Volume Changes in Patients with Diffuse Intrinsic Pontine Glioma Treated with an Anti-Vascular Endothelial Growth Factor Agent, Steroids, and Radiation.Molecular MRI of VEGFR-2 reveals intra-tumor and inter-tumor heterogeneity.Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and br Glioma Grading and Determination of IDH Mutation Status and ATRX loss by DCE and ASL Perfusion.The association of osteopontin and LMX1A expression with World Health Organization grade in meningiomas and gliomas.Reduced glioma growth following dexamethasone or anti-angiopoietin 2 treatment.Effects of targeting the VEGF and PDGF pathways in diffuse orthotopic glioma models.

P2860

Q28067399-BBBB282C-56D0-42AC-892C-65015EC2B6AF Q33588438-5011A2C6-397F-48EE-B804-D1C9AFAE0EC1 Q33933312-EA9AE67B-0D98-4D43-AC3A-9E4810386D10 Q34557146-AE49946C-7D23-454B-BC84-2886BB576FA6 Q34661966-473FE707-B95E-4EF6-92E2-446AECEC97B3 Q35103863-15C1B13E-C2FD-40B5-9E93-F020908A9B4A Q35249827-A56BA31E-03CF-460B-B5CB-55B6751FACD0 Q35525772-553A5E6C-1923-4BCA-8CD6-30419E0CC97B Q35742619-E6C3888E-D221-4563-B81B-A09E4EA98525 Q35929722-4FC2808E-CE6B-4E9E-82B9-5FE9709C8C90 Q35946168-B13AF72A-725A-472C-927E-089F95B742E6 Q36120388-328BF01A-34FA-422D-858A-8C680CA54169 Q36478647-1FF66A3E-62E0-46F3-B80C-45FBB87370E3 Q36947173-582F9632-03AF-43D0-8A02-88FEAABECA32 Q37004664-5B395C3F-3300-4508-9EC3-8B623C0AB7F7 Q37504362-9C82EDD1-CDFB-44D7-82F3-6C7889F983D9 Q37533652-752C7EE9-6302-4728-8462-D7CBD127DB5C Q37734481-4D55A46F-6EB2-43C4-BA8B-FBCD313852D4 Q37736273-CC8FD542-E88C-4F12-8C8C-DE71E550CC82 Q38258726-1608EA17-1835-49A2-8EA3-C0DD7FACFCDC Q38827788-C350E91D-44AE-4D1A-864A-961F085A0DD5 Q43085872-7F27EB6C-7A11-40E9-B934-BB095EBA0E44 Q48130398-45F897E7-511A-4070-A94E-5A972F9B3003 Q48167305-98F5B95B-A6A7-46C0-BB8D-33501AB2E406 Q48413541-24A46A1F-87FA-4F7A-82CA-AD5321DB0765 Q54540158-C0BCBD3A-C0F6-4C0F-B852-0F78E1F0FC0A Q55463372-6AD45317-BC4B-41B1-8612-D7C664E61C0F

P2860

Angiogenesis in gliomas: imaging and experimental therapeutics.

http://www.wikidata.org/entity/Q31028310

description

2005 nî lūn-bûn

@nan

2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Angiogenesis in gliomas: imaging and experimental therapeutics.

@ast

Angiogenesis in gliomas: imaging and experimental therapeutics.

@en

type

label

Angiogenesis in gliomas: imaging and experimental therapeutics.

@ast

Angiogenesis in gliomas: imaging and experimental therapeutics.

@en

prefLabel

Angiogenesis in gliomas: imaging and experimental therapeutics.

@ast

Angiogenesis in gliomas: imaging and experimental therapeutics.

@en

P1433

Q31028310-CCDD4E1B-84B1-4994-B689-E7E3897C9F73

P1476

Q31028310-876DDD0B-F919-4B7C-918C-C18E746AF901

P2093

Q31028310-0F07BA40-9D63-4192-A141-51C8C83C1564

Q31028310-5B1A8200-3A3E-4080-AC3C-1807EE6C2532

Q31028310-83992819-D7F7-4813-A97B-8BC86D90997B

Q31028310-B9A1F98A-49E7-4A24-8D71-69FB1D0CD147

Q31028310-CA7763C0-6FFF-4021-84E6-EE24E456EE1E

P2860

Q31028310-067706C7-1F38-4005-A17B-B8193E38FCA7

Q31028310-0B915326-4A6D-41DE-B08D-B32772FFAD79

Q31028310-0C1CD430-3CDC-4692-BE95-07133434A218

Q31028310-13C3EE16-15CB-48C6-9DC8-F06DDD210B15

Q31028310-1EFA844A-EE5C-4FC6-92C4-B9C228A32907

Q31028310-217AB8B6-1CA7-465C-9372-36DDD106F9E1

Q31028310-402DA807-4046-4576-B79B-C332AFD5FC9D

Q31028310-42C00494-8601-47F8-A04D-A305527FD906

Q31028310-5204D998-2EED-4EA9-A534-701F66A037D7

Q31028310-57397AE8-36F8-48B1-AE84-2074206FDF73

P304

Q31028310-14E1525E-6E19-42AB-B14C-601D235003D0

P31

Q31028310-DCFE1488-7CE8-49FE-8AB8-997C3128C459

P356

Q31028310-A7CC614B-E401-4E5C-A3A1-ECEBC3F0BC5A

P433

Q31028310-057B8A2B-E828-4643-A809-90E5FC5BB3DD

P478

Q31028310-F9D94E6B-1D94-4A6B-B216-CA77E3E81153

P577

Q31028310-8EF6B24A-B0B1-4909-8658-177CE5CFEE14

P698

Q31028310-2052EB39-6340-4BB4-AAE1-E3569D17ECC7

P356

J.1750-3639.2005.TB00119.X

P1433

Brain Pathology

P1476

Angiogenesis in gliomas: imaging and experimental therapeutics.

@en

P2093

David Zagzag

http://www.w3.org/2001/XMLSchema#string

Elizabeth W Newcomb

http://www.w3.org/2001/XMLSchema#string

Ingeborg Fischer

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre Gagner

http://www.w3.org/2001/XMLSchema#string

Meng Law

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular Imaging

PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration

Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: a quantitative multi-parameter analysis.

The contribution of epidermal growth factor receptor (EGFR) signaling pathway to radioresistance in human gliomas: a review of preclinical and correlative clinical data.

Targeting the Tie2/Tek receptor in astrocytomas.

Rationale and clinical basis for combining gefitinib (IRESSA, ZD1839) with radiation therapy for solid tumors.

Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer.

Neutralization of adrenomedullin inhibits the growth of human glioblastoma cell lines in vitro and suppresses tumor xenograft growth in vivo.

Vascularity and perfusion of human gliomas xenografted in the athymic nude mouse.

Immunohistochemically determined total epidermal growth factor receptor levels not of prognostic value in newly diagnosed glioblastoma multiforme: report from the Radiation Therapy Oncology Group.

P304

342-363

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1750-3639.2005.TB00119.X

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16389946

http://www.w3.org/2001/XMLSchema#string